sotrovimab   Click here for help

GtoPdb Ligand ID: 11333

Synonyms: GSK-4182136 | GSK4182136 | VIR-7831 | VIR7831 | Xevudy®
Approved drug
sotrovimab is an approved drug (UK (2021))
Compound class: Antibody
Comment: Sotrovimab (VIR-7831) is a monoclonal antibody against the surface spike protein of SARS-CoV-2. It was developed by GSK and Vir Biotechnology as a COVID-19 therapeutic [1].
Classification Click here for help
Compound class Antibody
Approved drug? Yes (UK (2021))
International Nonproprietary Names Click here for help
INN number INN
11766 sotrovimab
Synonyms Click here for help
GSK-4182136 | GSK4182136 | VIR-7831 | VIR7831 | Xevudy®
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 1110
Other databases
GtoPdb PubChem SID 434321768
Search PubMed clinical trials sotrovimab
Search PubMed titles sotrovimab
Search PubMed titles/abstracts sotrovimab